1-9 of 9
Steven Ziesmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IL-10 Contributes to the Development of Immunosuppressive CD14+HLA-DR low/- monocytes in B-Cell Non-Hodgkin’s Lymphoma

Bing Xiu, MD PhD, Yi Lin, MD PhD, Deanna Grote, BA, Steven Ziesmer, Michael Gustafson, PhD, Mary Maas, Zhe Zhang, PhD, Allan B Dietz, PhD, Aibin Liang, MD PhD, Luis F. Porrata, MD, Anne J. Novak, PhD, Zhi-Zhang Yang, MD, Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2979.
https://doi.org/10.1182/blood.V124.21.2979.2979
Published: 2014
Journal Articles

Activation Of TAK1 By MYD88 L265P Drives Malignant B Cell Growth In Non-Hodgkin Lymphomas

Stephen M Ansell, M.D., Ph.D., Lucy S. Hodge, PharmD, Ph.D., Frank Secreto, Michelle Manske, Esteban Braggio, Ph.D., TAmmy Price-Troska, Steven Ziesmer, Ying Li, Sarah Johnson, Steven Hart, Jean-Pierre Kocher, George Vasmatzis, PhD, Asher Chanan-Khan, MD, Morie Abraham Gertz, MD, Rafael Fonseca, MD, Ahmet Dogan, MD, PhD, James R Cerhan, MD, PhD, Anne J. Novak, PhD
Journal: Blood
Blood (2013) 122 (21): 245.
https://doi.org/10.1182/blood.V122.21.245.245
Published: 2013
Journal Articles

t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth

Stephen M. Ansell, Takashi Akasaka, Ellen McPhail, Michelle Manske, Esteban Braggio, Tammy Price-Troska, Steven Ziesmer, Frank Secreto, Rafael Fonseca, Mamta Gupta, Mark Law, Thomas E. Witzig, Martin J. S. Dyer, Ahmet Dogan, James R. Cerhan, Anne J. Novak
Journal: Blood
Blood (2012) 120 (19): 3949–3957.
https://doi.org/10.1182/blood-2011-11-389908
Published: 2012
Includes: Supplemental data
Journal Articles

GATA-3 or T-Bet Expression In PTCL-U Identify High-Risk Patients with Poor Outcomes and Distinct Clinical Characteristics Suggesting Their Derivation From Specific Subsets of T Helper Cells

Ryan A. Wilcox, MD, PhD, Andrew L Feldman, MD, Kay Ristow, Thomas M. Habermann, MD, Steven Ziesmer, Linda Wellik, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4125.
https://doi.org/10.1182/blood.V116.21.4125.4125
Published: 2010
Journal Articles

A BAFF-R Mutation Associated with Non-Hodgkin Lymphoma Exhibits Altered TRAF Binding and Reveals New Insights Into Proximal BAFF-R Signaling

Joanne M. Hildebrand, PhD, Zhenghua Luo, Michelle Manske, Steven Ziesmer, Tammy Price-troska, Wai Lin, Bruce Hostager, PhD, Susan Slager, PhD, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD, James Cerhan, MD, PhD, Gail Bishop, PhD, Anne J. Novak, PhD
Journal: Blood
Blood (2010) 116 (21): 468.
https://doi.org/10.1182/blood.V116.21.468.468
Published: 2010
Journal Articles

A Novel IL-12-TIM-3 Pathway Induces T Cell Exhaustion and Predicts Reduced Survival In Patients with Follicular B-Cell Non-Hodgkin Lymphoma

Zhi-Zhang Yang, MD, Deanna Grote, Steven Ziesmer, Toshiro Niki, Mitsuomi Hirashima, Anne J. Novak, PhD, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 143.
https://doi.org/10.1182/blood.V116.21.143.143
Published: 2010
Journal Articles

GLI2, An Effector of the Hedgehog Pathway, Is a Novel Regulator of IL6 Oncogenic Function In the Tumor Microenvironment

Sherine F. Elsawa, PhD, Luciana L. Almada, PhD, Steven Ziesmer, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD, Martin E. Fernandez-Zapico, MD
Journal: Blood
Blood (2010) 116 (21): 613.
https://doi.org/10.1182/blood.V116.21.613.613
Published: 2010
Journal Articles

A Newly Identified Translocation t(X;14)(p11;q32) In MALT Lymphoma Involving IGHS and GPR34 Reveals A Novel Role for GPR34 In Cell Growth and Tumor Development

Stephen M. Ansell, MD, PhD, Takashi Akasaka, MD, PhD, Michelle Manske, Tammy Price-troska, Steven Ziesmer, Esteban Braggio, Rafael Fonseca, Mamta Gupta, Ph.D, Mark E Law, Thomas E. Witzig, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Ahmet Dogan, M.D., Ph.D., Anne J. Novak, PhD
Journal: Blood
Blood (2010) 116 (21): 1999.
https://doi.org/10.1182/blood.V116.21.1999.1999
Published: 2010
Journal Articles

Serum Cytokine Levels Predict Time to Progression after Rituximab as Initial Therapy in Patients with Follicular Grade 1 Non-Hodgkin Lymphoma.

Stephen M. Ansell, Anne J. Novak, Steven Ziesmer, Betsy LaPlant, James R. Cerhan, Zhi-Zhang Yang, Stacey R. Dillon, Thomas E. Witzig
Journal: Blood
Blood (2007) 110 (11): 3410.
https://doi.org/10.1182/blood.V110.11.3410.3410
Published: 2007